Logo image of JBSS

JOHN B. SANFILIPPO & SON INC (JBSS) Stock Fundamental Analysis

NASDAQ:JBSS - Nasdaq - US8004221078 - Common Stock - Currency: USD

66.25  -1.48 (-2.19%)

After market: 66.25 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to JBSS. JBSS was compared to 91 industry peers in the Food Products industry. While JBSS has a great profitability rating, there are some minor concerns on its financial health. JBSS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

JBSS had positive earnings in the past year.
In the past year JBSS had a positive cash flow from operations.
In the past 5 years JBSS has always been profitable.
In the past 5 years JBSS always reported a positive cash flow from operatings.
JBSS Yearly Net Income VS EBIT VS OCF VS FCFJBSS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

1.2 Ratios

The Return On Assets of JBSS (9.39%) is better than 91.21% of its industry peers.
JBSS has a better Return On Equity (15.99%) than 83.52% of its industry peers.
JBSS has a Return On Invested Capital of 11.65%. This is amongst the best in the industry. JBSS outperforms 87.91% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for JBSS is significantly below the industry average of 28.10%.
The 3 year average ROIC (17.40%) for JBSS is well above the current ROIC(11.65%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 9.39%
ROE 15.99%
ROIC 11.66%
ROA(3y)13.43%
ROA(5y)13.71%
ROE(3y)20.79%
ROE(5y)21.94%
ROIC(3y)17.4%
ROIC(5y)18.17%
JBSS Yearly ROA, ROE, ROICJBSS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 5.00%, JBSS is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
JBSS's Profit Margin has improved in the last couple of years.
JBSS has a Operating Margin of 7.15%. This is in the better half of the industry: JBSS outperforms 68.13% of its industry peers.
JBSS's Operating Margin has improved in the last couple of years.
JBSS has a Gross Margin of 18.48%. This is comparable to the rest of the industry: JBSS outperforms 47.25% of its industry peers.
JBSS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.15%
PM (TTM) 5%
GM 18.48%
OM growth 3Y-7.81%
OM growth 5Y3.1%
PM growth 3Y-6.7%
PM growth 5Y4.61%
GM growth 3Y-2.34%
GM growth 5Y2.13%
JBSS Yearly Profit, Operating, Gross MarginsJBSS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

5

2. Health

2.1 Basic Checks

JBSS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
JBSS has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for JBSS has been increased compared to 5 years ago.
JBSS has a worse debt/assets ratio than last year.
JBSS Yearly Shares OutstandingJBSS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
JBSS Yearly Total Debt VS Total AssetsJBSS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

JBSS has an Altman-Z score of 5.13. This indicates that JBSS is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 5.13, JBSS belongs to the best of the industry, outperforming 86.81% of the companies in the same industry.
A Debt/Equity ratio of 0.28 indicates that JBSS is not too dependend on debt financing.
JBSS has a better Debt to Equity ratio (0.28) than 67.03% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF N/A
Altman-Z 5.13
ROIC/WACC1.28
WACC9.12%
JBSS Yearly LT Debt VS Equity VS FCFJBSS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

JBSS has a Current Ratio of 2.01. This indicates that JBSS is financially healthy and has no problem in meeting its short term obligations.
JBSS has a Current ratio of 2.01. This is in the better half of the industry: JBSS outperforms 67.03% of its industry peers.
A Quick Ratio of 0.53 indicates that JBSS may have some problems paying its short term obligations.
With a Quick ratio value of 0.53, JBSS is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.01
Quick Ratio 0.53
JBSS Yearly Current Assets VS Current LiabilitesJBSS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

2

3. Growth

3.1 Past

JBSS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.75%.
Measured over the past years, JBSS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.51% on average per year.
The Revenue has been growing slightly by 7.40% in the past year.
Measured over the past years, JBSS shows a small growth in Revenue. The Revenue has been growing by 4.01% on average per year.
EPS 1Y (TTM)-14.75%
EPS 3Y-0.06%
EPS 5Y8.51%
EPS Q2Q%49.57%
Revenue 1Y (TTM)7.4%
Revenue growth 3Y7.51%
Revenue growth 5Y4.01%
Sales Q2Q%-4.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JBSS Yearly Revenue VS EstimatesJBSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
JBSS Yearly EPS VS EstimatesJBSS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2024 1 2 3 4 5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 13.98, JBSS is valued correctly.
69.23% of the companies in the same industry are more expensive than JBSS, based on the Price/Earnings ratio.
JBSS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.50.
Industry RankSector Rank
PE 13.98
Fwd PE N/A
JBSS Price Earnings VS Forward Price EarningsJBSS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of JBSS indicates a somewhat cheap valuation: JBSS is cheaper than 72.53% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.59
JBSS Per share dataJBSS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

The excellent profitability rating of JBSS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.64
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.27%, JBSS has a reasonable but not impressive dividend return.
JBSS's Dividend Yield is comparable with the industry average which is at 4.72.
With a Dividend Yield of 1.27, JBSS pays less dividend than the S&P500 average, which is at 2.35.
Industry RankSector Rank
Dividend Yield 1.27%

5.2 History

The dividend of JBSS has a limited annual growth rate of 3.19%.
JBSS has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)3.19%
Div Incr Years0
Div Non Decr Years0
JBSS Yearly Dividends per shareJBSS Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3 4 5

5.3 Sustainability

65.00% of the earnings are spent on dividend by JBSS. This is not a sustainable payout ratio.
The dividend of JBSS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP65%
EPS Next 2YN/A
EPS Next 3YN/A
JBSS Yearly Income VS Free CF VS DividendJBSS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M
JBSS Dividend Payout.JBSS Dividend Payout, showing the Payout Ratio.JBSS Dividend Payout.PayoutRetained Earnings

More info and screens

JOHN B. SANFILIPPO & SON INC

NASDAQ:JBSS (7/18/2025, 8:00:02 PM)

After market: 66.25 0 (0%)

66.25

-1.48 (-2.19%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)08-18 2025-08-18
Inst Owners92.71%
Inst Owner Change0.01%
Ins Owners0.96%
Ins Owner Change-7.47%
Market Cap779.10M
Analysts85.71
Price TargetN/A
Short Float %2.21%
Short Ratio2.02
Dividend
Industry RankSector Rank
Dividend Yield 1.27%
Yearly Dividend3
Dividend Growth(5Y)3.19%
DP65%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.98
Fwd PE N/A
P/S 0.7
P/FCF N/A
P/OCF 26.64
P/B 2.25
P/tB 2.36
EV/EBITDA 7.59
EPS(TTM)4.74
EY7.15%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.6
FCFYN/A
OCF(TTM)2.49
OCFY3.75%
SpS94.2
BVpS29.47
TBVpS28.07
PEG (NY)N/A
PEG (5Y)1.64
Profitability
Industry RankSector Rank
ROA 9.39%
ROE 15.99%
ROCE 19.05%
ROIC 11.66%
ROICexc 11.68%
ROICexgc 12.08%
OM 7.15%
PM (TTM) 5%
GM 18.48%
FCFM N/A
ROA(3y)13.43%
ROA(5y)13.71%
ROE(3y)20.79%
ROE(5y)21.94%
ROIC(3y)17.4%
ROIC(5y)18.17%
ROICexc(3y)17.45%
ROICexc(5y)18.22%
ROICexgc(3y)18.35%
ROICexgc(5y)19.31%
ROCE(3y)24.69%
ROCE(5y)25.84%
ROICexcg growth 3Y-10.65%
ROICexcg growth 5Y0.4%
ROICexc growth 3Y-9.97%
ROICexc growth 5Y1.18%
OM growth 3Y-7.81%
OM growth 5Y3.1%
PM growth 3Y-6.7%
PM growth 5Y4.61%
GM growth 3Y-2.34%
GM growth 5Y2.13%
F-Score3
Asset Turnover1.88
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF N/A
Debt/EBITDA 0.91
Cap/Depr 181.92%
Cap/Sales 4.34%
Interest Coverage 250
Cash Conversion 27.68%
Profit Quality N/A
Current Ratio 2.01
Quick Ratio 0.53
Altman-Z 5.13
F-Score3
WACC9.12%
ROIC/WACC1.28
Cap/Depr(3y)104.47%
Cap/Depr(5y)106.99%
Cap/Sales(3y)2.2%
Cap/Sales(5y)2.25%
Profit Quality(3y)96.67%
Profit Quality(5y)102.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-14.75%
EPS 3Y-0.06%
EPS 5Y8.51%
EPS Q2Q%49.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.4%
Revenue growth 3Y7.51%
Revenue growth 5Y4.01%
Sales Q2Q%-4.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.8%
EBIT growth 3Y-0.88%
EBIT growth 5Y7.24%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-122.41%
FCF growth 3Y-2.64%
FCF growth 5Y1.41%
OCF growth 1Y-72.04%
OCF growth 3Y-0.97%
OCF growth 5Y4.02%